Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment

Mirogabalin (DS‐5565) is a novel preferentially selective α(2)δ‐1 ligand being developed for the treatment of diabetic peripheral neuropathic pain and postherpetic neuralgia. The current multicenter open‐label study determined the effect of varying degrees of renal impairment on the pharmacokinetics...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Pharmacol
Main Authors: Kato, Manabu, Tajima, Naoyuki, Shimizu, Takako, Sugihara, Masahiro, Furihata, Kenichi, Harada, Kazuhiro, Ishizuka, Hitoshi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Special Populations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5763271/
https://ncbi.nlm.nih.gov/pubmed/28834546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.974
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados